Marco Iannetta

2.8k total citations
94 papers, 1.6k citations indexed

About

Marco Iannetta is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Marco Iannetta has authored 94 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 28 papers in Epidemiology and 14 papers in Oncology. Recurrent topics in Marco Iannetta's work include COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and Polyomavirus and related diseases (13 papers). Marco Iannetta is often cited by papers focused on COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and Polyomavirus and related diseases (13 papers). Marco Iannetta collaborates with scholars based in Italy, France and United States. Marco Iannetta's co-authors include Vincenzo Vullo, Claudio Maria Mastroianni, Giuseppe Ippolito, Emanuele Nicastri, Maria Rosaria Capobianchi, Concetta Castilletti, Giuseppina Liuzzi, Massimo Andreoni, Alessandra Oliva and Alessandra D’Abramo and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Marco Iannetta

87 papers receiving 1.6k citations

Peers

Countries citing papers authored by Marco Iannetta

Since Specialization

Citations

This map shows the geographic impact of Marco Iannetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Iannetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Iannetta more than expected).

Fields of papers citing papers by Marco Iannetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Iannetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Iannetta. The network helps show where Marco Iannetta may publish in the future.

Co-authorship network of co-authors of Marco Iannetta

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Iannetta. A scholar is included among the top collaborators of Marco Iannetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Iannetta. Marco Iannetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterisation of four novel bacteriophages targeting carbapenem-resistant Klebsiella pneumoniae and their lytic activity alone and in combination 2025 ·Current Research in Microbial Sciences ·(unknown), (unknown), Novella Cesta, Cesira Giordano, Simona Barnini, М. Marchetti, (unknown), Rob Lavigne, (unknown), Cartesio D’Agostini, Marco Iannetta, Vincenzo Malagnino, Arianna Tavanti, Loredana Sarmati, Mariagrazia Di Luca	0
2	Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis 2025 ·International Journal of Antimicrobial Agents ·Novella Cesta, Adelaide Fusco, (unknown), (unknown), (unknown), Cartesio D’Agostini, Marco Iannetta, Massimo Andreoni, Arianna Tavanti, Loredana Sarmati, Mariagrazia Di Luca	0
3	Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis 2024 ·Drug Safety ·(unknown), Drieda Zaçe, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vincenzo Malagnino, Loredana Sarmati, Marco Iannetta	8
4	Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 2023 ·Open Forum Infectious Diseases ·Laura Campogiani, (unknown), (unknown), (unknown), Luigi Coppola, Mirko Compagno, (unknown), (unknown), Vincenzo Malagnino, Elisabetta Teti, Cartesio D’Agostini, (unknown), (unknown), (unknown), Massimo Andreoni, Marco Iannetta, Loredana Sarmati	3
5	Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 2023 ·Antibiotics ·Laura Campogiani, (unknown), A Lodi, (unknown), Carla Fontana, Cartesio D’Agostini, Mirko Compagno, Luigi Coppola, (unknown), Vincenzo Malagnino, Elisabetta Teti, Marco Iannetta, Massimo Andreoni, Loredana Sarmati	8
6	The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 2023 ·Antibiotics ·Andrea Di Lorenzo, Laura Campogiani, Marco Iannetta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vincenzo Malagnino, Elisabetta Teti, Massimo Andreoni, Loredana Sarmati	3
7	Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model 2023 ·International Immunopharmacology ·(unknown), Marilena P. Etna, Martina Severa, Stefano Fiore, (unknown), Marco Iannetta, Massimo Andreoni, Stefano Balducci, Paola Stefanelli, Anna Teresa Palamara, Eliana M. Coccia	5
8	Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk 2023 ·Biology ·Maria Antonella Zingaropoli, Patrizia Pasculli, (unknown), (unknown), (unknown), (unknown), Valentina Perri, (unknown), Gina Ferrazzano, Marco Iannetta, Cosmo Del Borgo, Miriam Lichtner, Claudio Maria Mastroianni, Antonella Conte, Maria Rosa Ciardi	3
9	T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review 2023 ·Journal of Personalized Medicine ·Domenico Umberto De Rose, (unknown), Francesca Ceccherini‐Silberstein, Andrea Dotta, Massimo Andreoni, Loredana Sarmati, Marco Iannetta	3
10	Human Arboviral Infections in Italy: Past, Current, and Future Challenges 2023 ·Viruses ·Benedetta Rossi, (unknown), Domenico Benvenuto, (unknown), Laura Campogiani, A Lodi, (unknown), (unknown), (unknown), (unknown), (unknown), Vincenzo Malagnino, Massimo Andreoni, Loredana Sarmati, Marco Iannetta	11
11	Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 2022 ·Journal of Clinical Medicine ·Carla Prezioso, Marco Ciotti, (unknown), Francesca Piacentini, (unknown), Alfonso Grimaldi, Doriana Landi, Carolina Gabri Nicoletti, Maria Antonella Zingaropoli, Marco Iannetta, Marta Altieri, Antonella Conte, Dolores Limongi, Girolama Alessandra Marfia, Maria Rosa Ciardi, Claudio Maria Mastroianni, Anna Teresa Palamara, Ugo Moens, Valeria Pietropaolo	3
12	Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization 2022 ·Open Forum Infectious Diseases ·Marco Iannetta, (unknown), Andrea Di Lorenzo, Laura Campogiani, Elisabetta Teti, Vincenzo Malagnino, Mirko Compagno, Luigi Coppola, Lorenzo Piermatteo, Giampiero Palmieri, (unknown), Romina Salpini, Maria Antonella Zingaropoli, Maria Rosa Ciardi, Claudio Maria Mastroianni, Saverio Giuseppe Parisi, Valentina Svicher, Massimo Andreoni, Loredana Sarmati	5
13	Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 2022 ·International Journal of Environmental Research and Public Health ·Mirko Compagno, Assunta Navarra, Laura Campogiani, Luigi Coppola, Benedetta Rossi, Marco Iannetta, Vincenzo Malagnino, Saverio Giuseppe Parisi, (unknown), Raffaella Cerretti, (unknown), Delia Goletti, Massimo Andreoni, Loredana Sarmati	1
14	Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 2021 ·PLoS Pathogens ·Martina Severa, Roberta A. Diotti, Marilena P. Etna, Fabiana Rizzo, Stefano Fiore, (unknown), Marco Iannetta, Alessandro Sinigaglia, A Lodi, Nicasio Mancini, Elena Criscuolo, Massimo Clementi, Massimo Andreoni, Stefano Balducci, Luisa Barzon, Paola Stefanelli, Nicola Clementi, Eliana M. Coccia	59
15	Impact of IFN‐Free and IFN‐Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan‐DC, and Activated T Lymphocyte Dynamics during HCV Infection 2020 ·Journal of Immunology Research ·Serena Vita, Paola Zuccalà, Stefano Savinelli, (unknown), (unknown), (unknown), Raffaella Marocco, Tiziana Tieghi, Marco Iannetta, Parni Nijhawan, Maria Antonella Zingaropoli, (unknown), Vincenzo Vullo, Claudio Maria Mastroianni, Miriam Lichtner	2
16	Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 2019 ·Scientific Reports ·Marco Iannetta, Maria Antonella Zingaropoli, Tiziana Latronico, Ilaria Pati, Simona Pontecorvo, Carla Prezioso, Valeria Pietropaolo, Antonio Cortese, Marco Frontoni, Claudia D’Agostino, Ada Francia, Vincenzo Vullo, Claudio Maria Mastroianni, Grazia Maria Liuzzi, Maria Rosa Ciardi	14
17	Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis 2018 ·Open Forum Infectious Diseases ·Maria Rosa Ciardi, Marco Iannetta, Maria Antonella Zingaropoli, Romina Salpini, M. Aragri, (unknown), Simona Pontecorvo, Marta Altieri, Gianluca Russo, Valentina Svicher, Claudio Maria Mastroianni, Vincenzo Vullo	54
18	ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC 2018 ·Mediators of Inflammation ·Francesca Colavita, Veronica Bordoni, Claudia Caglioti, Mirella Biava, Concetta Castilletti, Licia Bordi, Serena Quartu, Marco Iannetta, Giuseppe Ippolito, Chiara Agrati, Maria Rosaria Capobianchi, Eleonora Lalle	18
19	Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 2018 ·Immunobiology ·Marco Iannetta, Stefano Savinelli, (unknown), (unknown), Raffaella Marocco, Serena Vita, Paola Zuccalà, Maria Antonella Zingaropoli, Fabio Mengoni, Anna Paola Massetti, (unknown), Gabriella d’Ettorre, Maria Rosa Ciardi, Claudio Maria Mastroianni, Vincenzo Vullo, Miriam Lichtner	4
20	JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus 2018 ·BioMed Research International ·Maria Antonella Zingaropoli, Marco Iannetta, Simona Pontecorvo, Elena Anzivino, Carla Prezioso, Donatella Maria Rodio, Manuela Morreale, Alessandra D’Abramo, Alessandra Oliva, Miriam Lichtner, Antonio Cortese, Marco Frontoni, Valeria Pietropaolo, Ada Francia, Claudio Maria Mastroianni, Vincenzo Vullo, Maria Rosa Ciardi	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact